DiscoverHealthcare Tomorrow: Pitching The Future
Healthcare Tomorrow: Pitching The Future
Claim Ownership

Healthcare Tomorrow: Pitching The Future

Author: healthcaretomorrowpitchingthefuture

Subscribed: 0Played: 0
Share

Description

Join us as we shine a light on medtech visionaries and dig into the eureka moment behind their innovation, the wider problem it's solving, and its potential impact on the future of healthcare.

5 Episodes
Reverse
Medication non-adherence is one of the biggest issues in healthcare today - and one of the most overlooked. It contributes to an estimated 200,000 premature deaths every year. And it costs the EU up to €125 billion annually. Today, we're joined by Kieran Daly, General Manager and Co-Founder of HealthBeacon - the smart sharps bin innovators. His company is tackling this issue head-on, using smart technology to help patients manage their medications at home. Kieran is here today to explain how better adherence doesn't just save lives… It transforms the economics of care.
Today, we're joined by Dr. Salvatore Viscomi, CEO and co-founder of Carna Health. Carna is an AI-driven platform built to detect, manage, and prevent Cardio-Kidney-Metabolic syndrome. In just the past year, they've secured funding, landed a spot on Fortune's Most Innovative Companies list, and launched pilots reaching 35,000 people in Cameroon. Now they're expanding into the Democratic Republic of Congo and Southeast Asia, with a US launch on the horizon. Salvatore is here to share how they're scaling impact — one screening at a time.
Today, we're joined by Dr. Ryan Samuels, former NHS doctor and director at Eolas Medical. In high-pressure settings like a night shift, clinicians need critical information fast - but too often, they're searching through fragmented systems with little support. Eolas Medical’s AI-powered 'answer engine' is already used by 85% of acute trusts and more than 350,000 UK clinicians. Ryan’s here to reveal why clinical empathy and technical fluency matter just as much as the technology itself - and why he believes both have been overlooked in the rush to adopt AI…
Today, we're joined by Dr. Lara Zibners, co-founder and chair of Calla Lily Clinical Care, a clinical-stage company pioneering vaginal drug delivery, with applications spanning fertility, menopause, cancer, and infectious disease. Calla Lily has recently been selected for Wellcome Leap's $50 million Focused Antibiotics programme - targeting a UTI treatment that spares the gut microbiome. Lara is here to share why solving for women means solving for everybody, and how rethinking drug delivery - rather than chasing new molecules - could reshape the fight against antibiotic resistance…
As healthcare moves beyond the hospital, we’re connecting more devices than ever. But that connectivity brings a new challenge: how do you keep it secure and manageable at scale? Today, we’re joined by Colin Neale, Principal Business Development Manager at Wireless Logic. He’s here to tell us how real-time data from connected assets can help providers spot risks earlier and protect patient environments…
Comments